MaxRets Ventures PLC - Directorate Change
Announcement provided by
MaxRets Ventures Plc · MAX15/03/2024 07:00
15 March 2024
MaxRets Ventures PLC
("MaxRets" or the "Company")
Directorate Change
MaxRets Ventures plc (AQSE: MAX) (the "Company" or "MaxRets"), an investing company focusing on early-stage growth or undervalued later stage businesses with strong upside potential, announces that Mr Martin Walton a director of the Company, has stepped down from the Board of the Company with immediate effect in order to focus on other business ventures.
The Company also announces the appointment of Mr Luciano Maranzana as Non-Executive Director of the Company. Mr Maranzana is currently the Group CEO of the AQSE quoted company Eight Capital Partners plc and has more than 30 years' experience in the investment management sector. Over his career he has invested and managed almost
Save as set out below, no further information regarding Mr Luciano Maranzana is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.
Mr Luciano Maranzana (aged 61) has held the following current and former directorships in the past five years:
Current Directorships |
Former Directorships in the past five years |
Eight Capital Partners plc |
Fase Reality SRL* |
Epsion Capital Limited |
Innovative Finance SRL* |
|
Negentropy Capital Partners Italia SRL* |
|
Realty SRL* |
|
Sulmo SRL* |
|
|
|
* Italian directorships |
The Directors of the Company are responsible for the content of this announcement.
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of
For further information please contact:
Enquiries:
MaxRets Ventures plc Dominic White, Non-Executive Chairman
|
c/o Walbrook PR Limited
|
Cairn Financial Advisers LLP AQSE Corporate Adviser Jo Turner/Emily Staples
|
+44 20 7213 0880 |
Walbrook PR Limited Paul Vann/Nick Rome/Joe Walker |
+44 20 7933 8780 +44 7768 807631
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.